– Eplontersen showed statistically significant and clinically meaningful improvements in mNIS+7 and Norfolk QoL-DN – Eplontersen demonstrated a favorable safety profile – Ionis and AstraZeneca expect to file a New Drug Application this year CARLSBAD, Calif.
Read more